nodes	percent_of_prediction	percent_of_DWPC	metapath
Sucralfate—ALB—acquired immunodeficiency syndrome	0.559	1	CbGaD
Sucralfate—ALB—Saquinavir—acquired immunodeficiency syndrome	0.0735	0.511	CbGbCtD
Sucralfate—ALB—Zidovudine—acquired immunodeficiency syndrome	0.0705	0.489	CbGbCtD
Sucralfate—FGB—blood plasma—acquired immunodeficiency syndrome	0.0129	0.0755	CbGeAlD
Sucralfate—FGA—blood plasma—acquired immunodeficiency syndrome	0.011	0.0646	CbGeAlD
Sucralfate—EGF—endothelium—acquired immunodeficiency syndrome	0.00905	0.0531	CbGeAlD
Sucralfate—EGF—blood plasma—acquired immunodeficiency syndrome	0.00804	0.0472	CbGeAlD
Sucralfate—PGA5—digestive system—acquired immunodeficiency syndrome	0.00727	0.0427	CbGeAlD
Sucralfate—PGA5—nervous system—acquired immunodeficiency syndrome	0.00563	0.033	CbGeAlD
Sucralfate—PGA5—central nervous system—acquired immunodeficiency syndrome	0.00542	0.0318	CbGeAlD
Sucralfate—FGG—lung—acquired immunodeficiency syndrome	0.00535	0.0314	CbGeAlD
Sucralfate—FGB—lymphoid tissue—acquired immunodeficiency syndrome	0.00501	0.0294	CbGeAlD
Sucralfate—FGB—digestive system—acquired immunodeficiency syndrome	0.00494	0.029	CbGeAlD
Sucralfate—FGB—blood—acquired immunodeficiency syndrome	0.00471	0.0277	CbGeAlD
Sucralfate—FGB—bone marrow—acquired immunodeficiency syndrome	0.00456	0.0268	CbGeAlD
Sucralfate—EGF—retina—acquired immunodeficiency syndrome	0.0044	0.0258	CbGeAlD
Sucralfate—PGA5—brain—acquired immunodeficiency syndrome	0.0043	0.0253	CbGeAlD
Sucralfate—FGA—lymphoid tissue—acquired immunodeficiency syndrome	0.00428	0.0252	CbGeAlD
Sucralfate—FGA—digestive system—acquired immunodeficiency syndrome	0.00423	0.0248	CbGeAlD
Sucralfate—FGB—lung—acquired immunodeficiency syndrome	0.00413	0.0243	CbGeAlD
Sucralfate—FGA—blood—acquired immunodeficiency syndrome	0.00403	0.0237	CbGeAlD
Sucralfate—FGA—bone marrow—acquired immunodeficiency syndrome	0.0039	0.0229	CbGeAlD
Sucralfate—EGF—skin of body—acquired immunodeficiency syndrome	0.00386	0.0227	CbGeAlD
Sucralfate—Lung disorder—Stavudine—acquired immunodeficiency syndrome	0.00378	0.108	CcSEcCtD
Sucralfate—FGG—lymph node—acquired immunodeficiency syndrome	0.00366	0.0215	CbGeAlD
Sucralfate—FGA—lung—acquired immunodeficiency syndrome	0.00353	0.0208	CbGeAlD
Sucralfate—FGA—nervous system—acquired immunodeficiency syndrome	0.00327	0.0192	CbGeAlD
Sucralfate—FGA—central nervous system—acquired immunodeficiency syndrome	0.00315	0.0185	CbGeAlD
Sucralfate—EGF—lymphoid tissue—acquired immunodeficiency syndrome	0.00313	0.0184	CbGeAlD
Sucralfate—EGF—digestive system—acquired immunodeficiency syndrome	0.00309	0.0181	CbGeAlD
Sucralfate—EGF—blood—acquired immunodeficiency syndrome	0.00294	0.0173	CbGeAlD
Sucralfate—EGF—spinal cord—acquired immunodeficiency syndrome	0.00284	0.0167	CbGeAlD
Sucralfate—EGF—vagina—acquired immunodeficiency syndrome	0.00273	0.016	CbGeAlD
Sucralfate—EGF—lung—acquired immunodeficiency syndrome	0.00258	0.0152	CbGeAlD
Sucralfate—Lung disorder—Ritonavir—acquired immunodeficiency syndrome	0.00255	0.0728	CcSEcCtD
Sucralfate—FGF2—spinal cord—acquired immunodeficiency syndrome	0.0025	0.0147	CbGeAlD
Sucralfate—FGA—brain—acquired immunodeficiency syndrome	0.0025	0.0147	CbGeAlD
Sucralfate—Lung disorder—Saquinavir—acquired immunodeficiency syndrome	0.00246	0.07	CcSEcCtD
Sucralfate—FGF2—vagina—acquired immunodeficiency syndrome	0.00241	0.0141	CbGeAlD
Sucralfate—EGF—nervous system—acquired immunodeficiency syndrome	0.00239	0.014	CbGeAlD
Sucralfate—EGF—central nervous system—acquired immunodeficiency syndrome	0.0023	0.0135	CbGeAlD
Sucralfate—FGF2—lung—acquired immunodeficiency syndrome	0.00228	0.0134	CbGeAlD
Sucralfate—Phlebitis—Zidovudine—acquired immunodeficiency syndrome	0.00196	0.0558	CcSEcCtD
Sucralfate—EGF—brain—acquired immunodeficiency syndrome	0.00183	0.0107	CbGeAlD
Sucralfate—EGF—lymph node—acquired immunodeficiency syndrome	0.00177	0.0104	CbGeAlD
Sucralfate—FGF2—brain—acquired immunodeficiency syndrome	0.00161	0.00947	CbGeAlD
Sucralfate—FGF2—lymph node—acquired immunodeficiency syndrome	0.00156	0.00915	CbGeAlD
Sucralfate—Phlebitis—Ritonavir—acquired immunodeficiency syndrome	0.00152	0.0434	CcSEcCtD
Sucralfate—Hyponatraemia—Delavirdine—acquired immunodeficiency syndrome	0.00142	0.0406	CcSEcCtD
Sucralfate—Phlebitis—Lamivudine—acquired immunodeficiency syndrome	0.0014	0.0398	CcSEcCtD
Sucralfate—Hyponatraemia—Saquinavir—acquired immunodeficiency syndrome	0.00127	0.0361	CcSEcCtD
Sucralfate—Infection—Didanosine—acquired immunodeficiency syndrome	0.00109	0.0311	CcSEcCtD
Sucralfate—Oedema—Nevirapine—acquired immunodeficiency syndrome	0.000989	0.0282	CcSEcCtD
Sucralfate—Oedema—Nelfinavir—acquired immunodeficiency syndrome	0.000958	0.0273	CcSEcCtD
Sucralfate—Oedema—Abacavir—acquired immunodeficiency syndrome	0.00094	0.0268	CcSEcCtD
Sucralfate—Infection—Abacavir—acquired immunodeficiency syndrome	0.000934	0.0266	CcSEcCtD
Sucralfate—Body temperature increased—Didanosine—acquired immunodeficiency syndrome	0.000869	0.0248	CcSEcCtD
Sucralfate—Oedema—Zidovudine—acquired immunodeficiency syndrome	0.00083	0.0236	CcSEcCtD
Sucralfate—EGF—Signaling by ERBB4—CXCL12—acquired immunodeficiency syndrome	0.000822	0.00897	CbGpPWpGaD
Sucralfate—EGF—SHP2 signaling—IFNG—acquired immunodeficiency syndrome	0.000792	0.00864	CbGpPWpGaD
Sucralfate—FGG—IL6-mediated signaling events—IL6—acquired immunodeficiency syndrome	0.000784	0.00856	CbGpPWpGaD
Sucralfate—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.000782	0.0223	CcSEcCtD
Sucralfate—Oedema—Indinavir—acquired immunodeficiency syndrome	0.000772	0.022	CcSEcCtD
Sucralfate—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.000757	0.0216	CcSEcCtD
Sucralfate—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.000755	0.0215	CcSEcCtD
Sucralfate—FGB—Platelet activation, signaling and aggregation—CSF2—acquired immunodeficiency syndrome	0.000747	0.00815	CbGpPWpGaD
Sucralfate—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.000743	0.0212	CcSEcCtD
Sucralfate—FGG—Platelet activation, signaling and aggregation—CSF2—acquired immunodeficiency syndrome	0.000731	0.00798	CbGpPWpGaD
Sucralfate—FGA—Platelet activation, signaling and aggregation—CSF2—acquired immunodeficiency syndrome	0.000731	0.00798	CbGpPWpGaD
Sucralfate—EGF—SHP2 signaling—IL2—acquired immunodeficiency syndrome	0.000703	0.00768	CbGpPWpGaD
Sucralfate—EGF—GRB2 events in ERBB2 signaling—IL6—acquired immunodeficiency syndrome	0.000701	0.00765	CbGpPWpGaD
Sucralfate—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000698	0.0199	CcSEcCtD
Sucralfate—EGF—Regulation of Telomerase—IFNG—acquired immunodeficiency syndrome	0.000697	0.00761	CbGpPWpGaD
Sucralfate—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000693	0.0197	CcSEcCtD
Sucralfate—EGF—Platelet degranulation—ALB—acquired immunodeficiency syndrome	0.000671	0.00732	CbGpPWpGaD
Sucralfate—EGF—SHC1 events in ERBB2 signaling—IL6—acquired immunodeficiency syndrome	0.000665	0.00726	CbGpPWpGaD
Sucralfate—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000656	0.0187	CcSEcCtD
Sucralfate—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000645	0.0184	CcSEcCtD
Sucralfate—EGF—Response to elevated platelet cytosolic Ca2+—ALB—acquired immunodeficiency syndrome	0.000639	0.00697	CbGpPWpGaD
Sucralfate—ALB—brain—acquired immunodeficiency syndrome	0.000631	0.00371	CbGeAlD
Sucralfate—EGF—B Cell Activation—CD79A—acquired immunodeficiency syndrome	0.000626	0.00683	CbGpPWpGaD
Sucralfate—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000621	0.0177	CcSEcCtD
Sucralfate—EGF—Regulation of Telomerase—IL2—acquired immunodeficiency syndrome	0.000619	0.00676	CbGpPWpGaD
Sucralfate—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000617	0.0176	CcSEcCtD
Sucralfate—ALB—lymph node—acquired immunodeficiency syndrome	0.00061	0.00358	CbGeAlD
Sucralfate—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.00061	0.0174	CcSEcCtD
Sucralfate—EGF—Ceramide signaling pathway—TNF—acquired immunodeficiency syndrome	0.000596	0.00651	CbGpPWpGaD
Sucralfate—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000592	0.0169	CcSEcCtD
Sucralfate—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000588	0.0168	CcSEcCtD
Sucralfate—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000576	0.0164	CcSEcCtD
Sucralfate—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000551	0.0157	CcSEcCtD
Sucralfate—FGB—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000547	0.00597	CbGpPWpGaD
Sucralfate—FGA—Disease—APOBEC3G—acquired immunodeficiency syndrome	0.000545	0.00595	CbGpPWpGaD
Sucralfate—EGF—TGF-beta Receptor Signaling—TNF—acquired immunodeficiency syndrome	0.000542	0.00592	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000536	0.00585	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000536	0.00585	CbGpPWpGaD
Sucralfate—EGF—Cardiac Hypertrophic Response—TNF—acquired immunodeficiency syndrome	0.000535	0.00583	CbGpPWpGaD
Sucralfate—EGF—DAP12 interactions—HLA-B—acquired immunodeficiency syndrome	0.000524	0.00572	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB4—CXCL12—acquired immunodeficiency syndrome	0.00052	0.00568	CbGpPWpGaD
Sucralfate—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.00051	0.0145	CcSEcCtD
Sucralfate—FGG—Glucocorticoid receptor regulatory network—IL6—acquired immunodeficiency syndrome	0.000502	0.00548	CbGpPWpGaD
Sucralfate—FGB—Hemostasis—IFNA1—acquired immunodeficiency syndrome	0.000492	0.00537	CbGpPWpGaD
Sucralfate—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000491	0.014	CcSEcCtD
Sucralfate—FGB—Platelet activation, signaling and aggregation—ALB—acquired immunodeficiency syndrome	0.000487	0.00531	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—IFNA1—acquired immunodeficiency syndrome	0.000482	0.00526	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—IFNA1—acquired immunodeficiency syndrome	0.000482	0.00526	CbGpPWpGaD
Sucralfate—EGF—Differentiation Pathway—IL6—acquired immunodeficiency syndrome	0.000481	0.00525	CbGpPWpGaD
Sucralfate—FGG—Platelet activation, signaling and aggregation—ALB—acquired immunodeficiency syndrome	0.000477	0.0052	CbGpPWpGaD
Sucralfate—FGA—Platelet activation, signaling and aggregation—ALB—acquired immunodeficiency syndrome	0.000477	0.0052	CbGpPWpGaD
Sucralfate—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000468	0.0133	CcSEcCtD
Sucralfate—EGF—Innate Immune System—ACTG1—acquired immunodeficiency syndrome	0.000467	0.00509	CbGpPWpGaD
Sucralfate—FGA—Disease—CCNT1—acquired immunodeficiency syndrome	0.000464	0.00506	CbGpPWpGaD
Sucralfate—EGF—Platelet activation, signaling and aggregation—CSF2—acquired immunodeficiency syndrome	0.000456	0.00498	CbGpPWpGaD
Sucralfate—EGF—SHP2 signaling—IL6—acquired immunodeficiency syndrome	0.000413	0.00451	CbGpPWpGaD
Sucralfate—FGF2—B Cell Activation—CD79A—acquired immunodeficiency syndrome	0.000396	0.00432	CbGpPWpGaD
Sucralfate—FGB—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	0.000395	0.00431	CbGpPWpGaD
Sucralfate—FGA—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	0.000387	0.00422	CbGpPWpGaD
Sucralfate—FGG—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	0.000387	0.00422	CbGpPWpGaD
Sucralfate—FGB—Hemostasis—CSF2—acquired immunodeficiency syndrome	0.000385	0.0042	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—MBL2—acquired immunodeficiency syndrome	0.000383	0.00419	CbGpPWpGaD
Sucralfate—EGF—MicroRNAs in cardiomyocyte hypertrophy—TNF—acquired immunodeficiency syndrome	0.000381	0.00416	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—CSF2—acquired immunodeficiency syndrome	0.000377	0.00412	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—CSF2—acquired immunodeficiency syndrome	0.000377	0.00412	CbGpPWpGaD
Sucralfate—FGF2—Angiopoietin receptor Tie2-mediated signaling—TNF—acquired immunodeficiency syndrome	0.000365	0.00399	CbGpPWpGaD
Sucralfate—ALB—Vitamin B12 Metabolism—CCL5—acquired immunodeficiency syndrome	0.000346	0.00377	CbGpPWpGaD
Sucralfate—EGF—Disease—APOBEC3G—acquired immunodeficiency syndrome	0.00034	0.00371	CbGpPWpGaD
Sucralfate—FGF2—Cardiac Hypertrophic Response—TNF—acquired immunodeficiency syndrome	0.000338	0.00369	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000334	0.00365	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—ACTG1—acquired immunodeficiency syndrome	0.000334	0.00365	CbGpPWpGaD
Sucralfate—FGF2—DAP12 interactions—HLA-B—acquired immunodeficiency syndrome	0.000332	0.00362	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000331	0.00362	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000331	0.00362	CbGpPWpGaD
Sucralfate—FGF2—FRS2-mediated cascade—IL6—acquired immunodeficiency syndrome	0.000326	0.00356	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000325	0.00354	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000325	0.00354	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000325	0.00354	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000325	0.00354	CbGpPWpGaD
Sucralfate—FGF2—Differentiation Pathway—IL6—acquired immunodeficiency syndrome	0.000304	0.00332	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—IFNA1—acquired immunodeficiency syndrome	0.000301	0.00328	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—CCR2—acquired immunodeficiency syndrome	0.000301	0.00328	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.0003	0.00327	CbGpPWpGaD
Sucralfate—EGF—Platelet activation, signaling and aggregation—ALB—acquired immunodeficiency syndrome	0.000297	0.00325	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—ACTG1—acquired immunodeficiency syndrome	0.000295	0.00322	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000294	0.00321	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000294	0.00321	CbGpPWpGaD
Sucralfate—EGF—Disease—CCNT1—acquired immunodeficiency syndrome	0.000289	0.00316	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—IL4—acquired immunodeficiency syndrome	0.000272	0.00297	CbGpPWpGaD
Sucralfate—EGF—Immune System—ACTG1—acquired immunodeficiency syndrome	0.000272	0.00297	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—IFNA1—acquired immunodeficiency syndrome	0.000271	0.00295	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—CD79A—acquired immunodeficiency syndrome	0.000252	0.00275	CbGpPWpGaD
Sucralfate—FGB—Hemostasis—ALB—acquired immunodeficiency syndrome	0.000251	0.00274	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—ALB—acquired immunodeficiency syndrome	0.000246	0.00268	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—ALB—acquired immunodeficiency syndrome	0.000246	0.00268	CbGpPWpGaD
Sucralfate—FGA—Disease—CXCR4—acquired immunodeficiency syndrome	0.000244	0.00266	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—MBL2—acquired immunodeficiency syndrome	0.000243	0.00265	CbGpPWpGaD
Sucralfate—EGF—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	0.000241	0.00263	CbGpPWpGaD
Sucralfate—FGF2—MicroRNAs in cardiomyocyte hypertrophy—TNF—acquired immunodeficiency syndrome	0.000241	0.00263	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—CSF2—acquired immunodeficiency syndrome	0.000235	0.00257	CbGpPWpGaD
Sucralfate—EGF—Immune System—MBL2—acquired immunodeficiency syndrome	0.000223	0.00244	CbGpPWpGaD
Sucralfate—EGF—MAPK Signaling Pathway—TNF—acquired immunodeficiency syndrome	0.000219	0.00239	CbGpPWpGaD
Sucralfate—FGF2—Disease—APOBEC3G—acquired immunodeficiency syndrome	0.000215	0.00235	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000212	0.00231	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—CD40LG—acquired immunodeficiency syndrome	0.000206	0.00225	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000205	0.00223	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—HLA-B—acquired immunodeficiency syndrome	0.000204	0.00222	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—CD8A—acquired immunodeficiency syndrome	0.000203	0.00222	CbGpPWpGaD
Sucralfate—FGB—Hemostasis—IL2—acquired immunodeficiency syndrome	0.000203	0.00222	CbGpPWpGaD
Sucralfate—EGF—Signaling by SCF-KIT—IL6—acquired immunodeficiency syndrome	0.000203	0.00222	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000203	0.00221	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000203	0.00221	CbGpPWpGaD
Sucralfate—ALB—Vitamin B12 Metabolism—IFNG—acquired immunodeficiency syndrome	0.000202	0.00221	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000201	0.00219	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000201	0.00219	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—IL2—acquired immunodeficiency syndrome	0.000199	0.00217	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—IL2—acquired immunodeficiency syndrome	0.000199	0.00217	CbGpPWpGaD
Sucralfate—EGF—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	0.000197	0.00216	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—HLA-B—acquired immunodeficiency syndrome	0.000196	0.00214	CbGpPWpGaD
Sucralfate—EGF—Downstream signaling of activated FGFR—IL6—acquired immunodeficiency syndrome	0.000194	0.00212	CbGpPWpGaD
Sucralfate—FGF2—IRS-mediated signalling—IL6—acquired immunodeficiency syndrome	0.000193	0.0021	CbGpPWpGaD
Sucralfate—EGF—Signaling by ERBB4—IL6—acquired immunodeficiency syndrome	0.000191	0.00209	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—CCR2—acquired immunodeficiency syndrome	0.00019	0.00208	CbGpPWpGaD
Sucralfate—FGF2—IRS-related events—IL6—acquired immunodeficiency syndrome	0.000187	0.00205	CbGpPWpGaD
Sucralfate—FGF2—IRS-related events triggered by IGF1R—IL6—acquired immunodeficiency syndrome	0.000186	0.00203	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000185	0.00202	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000183	0.002	CbGpPWpGaD
Sucralfate—FGF2—Disease—CCNT1—acquired immunodeficiency syndrome	0.000183	0.002	CbGpPWpGaD
Sucralfate—EGF—Downstream signal transduction—IL6—acquired immunodeficiency syndrome	0.000183	0.00199	CbGpPWpGaD
Sucralfate—EGF—Signaling by FGFR—IL6—acquired immunodeficiency syndrome	0.000182	0.00198	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000181	0.00198	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000181	0.00198	CbGpPWpGaD
Sucralfate—FGF2—IGF1R signaling cascade—IL6—acquired immunodeficiency syndrome	0.000181	0.00197	CbGpPWpGaD
Sucralfate—FGF2—Insulin receptor signalling cascade—IL6—acquired immunodeficiency syndrome	0.000181	0.00197	CbGpPWpGaD
Sucralfate—EGF—Signaling by ERBB2—IL6—acquired immunodeficiency syndrome	0.000181	0.00197	CbGpPWpGaD
Sucralfate—EGF—DAP12 signaling—IL6—acquired immunodeficiency syndrome	0.00018	0.00196	CbGpPWpGaD
Sucralfate—EGF—Immune System—CCR2—acquired immunodeficiency syndrome	0.000175	0.00191	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000174	0.0019	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000174	0.0019	CbGpPWpGaD
Sucralfate—FGF2—Immune System—ACTG1—acquired immunodeficiency syndrome	0.000172	0.00188	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—IFNA1—acquired immunodeficiency syndrome	0.000171	0.00187	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000171	0.00186	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000171	0.00186	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000171	0.00186	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000171	0.00186	CbGpPWpGaD
Sucralfate—EGF—Signaling by FGFR in disease—IL6—acquired immunodeficiency syndrome	0.000169	0.00185	CbGpPWpGaD
Sucralfate—EGF—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	0.000169	0.00185	CbGpPWpGaD
Sucralfate—EGF—DAP12 interactions—IL6—acquired immunodeficiency syndrome	0.000169	0.00185	CbGpPWpGaD
Sucralfate—EGF—Signaling by EGFR—IL6—acquired immunodeficiency syndrome	0.000168	0.00183	CbGpPWpGaD
Sucralfate—FGA—Disease—CCR5—acquired immunodeficiency syndrome	0.000167	0.00182	CbGpPWpGaD
Sucralfate—EGF—Signaling by EGFR in Cancer—IL6—acquired immunodeficiency syndrome	0.000166	0.00182	CbGpPWpGaD
Sucralfate—EGF—Signaling by PDGF—IL6—acquired immunodeficiency syndrome	0.000166	0.00181	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—IFNG—acquired immunodeficiency syndrome	0.000165	0.0018	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—CD79A—acquired immunodeficiency syndrome	0.00016	0.00174	CbGpPWpGaD
Sucralfate—EGF—Immune System—IFNA1—acquired immunodeficiency syndrome	0.000158	0.00172	CbGpPWpGaD
Sucralfate—ALB—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.000157	0.00171	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—ALB—acquired immunodeficiency syndrome	0.000153	0.00167	CbGpPWpGaD
Sucralfate—EGF—Immune System—CD79A—acquired immunodeficiency syndrome	0.000153	0.00167	CbGpPWpGaD
Sucralfate—EGF—Disease—CXCR4—acquired immunodeficiency syndrome	0.000152	0.00166	CbGpPWpGaD
Sucralfate—FGF2—Signaling by Insulin receptor—IL6—acquired immunodeficiency syndrome	0.00015	0.00164	CbGpPWpGaD
Sucralfate—EGF—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	0.00015	0.00164	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—IL2—acquired immunodeficiency syndrome	0.000146	0.0016	CbGpPWpGaD
Sucralfate—FGF2—Immune System—MBL2—acquired immunodeficiency syndrome	0.000141	0.00154	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000132	0.00145	CbGpPWpGaD
Sucralfate—ALB—Vitamin B12 Metabolism—TNF—acquired immunodeficiency syndrome	0.000131	0.00143	CbGpPWpGaD
Sucralfate—ALB—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	0.000131	0.00143	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.00013	0.00142	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—CD40LG—acquired immunodeficiency syndrome	0.00013	0.00142	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.00013	0.00142	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.00013	0.00142	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—HLA-B—acquired immunodeficiency syndrome	0.000129	0.00141	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—CD8A—acquired immunodeficiency syndrome	0.000129	0.00141	CbGpPWpGaD
Sucralfate—FGF2—Signaling by SCF-KIT—IL6—acquired immunodeficiency syndrome	0.000129	0.0014	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000128	0.0014	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000128	0.0014	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000128	0.0014	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000128	0.0014	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000125	0.00137	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	0.000125	0.00136	CbGpPWpGaD
Sucralfate—EGF—Immune System—CD40LG—acquired immunodeficiency syndrome	0.000125	0.00136	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—IL2—acquired immunodeficiency syndrome	0.000124	0.00136	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—HLA-B—acquired immunodeficiency syndrome	0.000124	0.00135	CbGpPWpGaD
Sucralfate—EGF—Immune System—CSF2—acquired immunodeficiency syndrome	0.000123	0.00135	CbGpPWpGaD
Sucralfate—EGF—Immune System—CD8A—acquired immunodeficiency syndrome	0.000123	0.00135	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling of activated FGFR—IL6—acquired immunodeficiency syndrome	0.000123	0.00134	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—CD4—acquired immunodeficiency syndrome	0.000122	0.00133	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB4—IL6—acquired immunodeficiency syndrome	0.000121	0.00132	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000119	0.0013	CbGpPWpGaD
Sucralfate—EGF—Immune System—HLA-B—acquired immunodeficiency syndrome	0.000119	0.0013	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000117	0.00128	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000117	0.00128	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	0.000117	0.00128	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000116	0.00127	CbGpPWpGaD
Sucralfate—FGF2—Downstream signal transduction—IL6—acquired immunodeficiency syndrome	0.000116	0.00126	CbGpPWpGaD
Sucralfate—EGF—Signaling by NGF—IL6—acquired immunodeficiency syndrome	0.000115	0.00126	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR—IL6—acquired immunodeficiency syndrome	0.000115	0.00126	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB2—IL6—acquired immunodeficiency syndrome	0.000114	0.00125	CbGpPWpGaD
Sucralfate—FGF2—DAP12 signaling—IL6—acquired immunodeficiency syndrome	0.000114	0.00124	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000113	0.00124	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CCR2—acquired immunodeficiency syndrome	0.000111	0.00121	CbGpPWpGaD
Sucralfate—FGF2—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	0.000107	0.00117	CbGpPWpGaD
Sucralfate—FGF2—DAP12 interactions—IL6—acquired immunodeficiency syndrome	0.000107	0.00117	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR in disease—IL6—acquired immunodeficiency syndrome	0.000107	0.00117	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—TNF—acquired immunodeficiency syndrome	0.000107	0.00116	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000106	0.00116	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000106	0.00116	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR—IL6—acquired immunodeficiency syndrome	0.000106	0.00116	CbGpPWpGaD
Sucralfate—ALB—Vitamin B12 Metabolism—IL6—acquired immunodeficiency syndrome	0.000106	0.00115	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—CSF2—acquired immunodeficiency syndrome	0.000105	0.00115	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR in Cancer—IL6—acquired immunodeficiency syndrome	0.000105	0.00115	CbGpPWpGaD
Sucralfate—FGA—Disease—CD4—acquired immunodeficiency syndrome	0.000105	0.00114	CbGpPWpGaD
Sucralfate—FGF2—Signaling by PDGF—IL6—acquired immunodeficiency syndrome	0.000105	0.00114	CbGpPWpGaD
Sucralfate—EGF—Disease—CCR5—acquired immunodeficiency syndrome	0.000104	0.00114	CbGpPWpGaD
Sucralfate—FGF2—Immune System—IFNA1—acquired immunodeficiency syndrome	9.98e-05	0.00109	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CD79A—acquired immunodeficiency syndrome	9.69e-05	0.00106	CbGpPWpGaD
Sucralfate—FGF2—Disease—CXCR4—acquired immunodeficiency syndrome	9.62e-05	0.00105	CbGpPWpGaD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	9.49e-05	0.00104	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—IL6—acquired immunodeficiency syndrome	8.6e-05	0.000939	CbGpPWpGaD
Sucralfate—ALB—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	8.47e-05	0.000924	CbGpPWpGaD
Sucralfate—ALB—Metabolism—TAT—acquired immunodeficiency syndrome	8.23e-05	0.000898	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	8.1e-05	0.000884	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.98e-05	0.000871	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	7.92e-05	0.000865	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CD40LG—acquired immunodeficiency syndrome	7.9e-05	0.000862	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CD8A—acquired immunodeficiency syndrome	7.81e-05	0.000852	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CSF2—acquired immunodeficiency syndrome	7.81e-05	0.000852	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—CD4—acquired immunodeficiency syndrome	7.7e-05	0.00084	CbGpPWpGaD
Sucralfate—FGF2—Immune System—HLA-B—acquired immunodeficiency syndrome	7.51e-05	0.00082	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	7.39e-05	0.000807	CbGpPWpGaD
Sucralfate—EGF—Immune System—IFNG—acquired immunodeficiency syndrome	7.34e-05	0.000801	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—IL6—acquired immunodeficiency syndrome	7.3e-05	0.000797	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.3e-05	0.000796	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	7.16e-05	0.000782	CbGpPWpGaD
Sucralfate—EGF—Immune System—CD4—acquired immunodeficiency syndrome	7.09e-05	0.000773	CbGpPWpGaD
Sucralfate—ALB—Metabolism—AGPS—acquired immunodeficiency syndrome	7e-05	0.000764	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—IFNA1—acquired immunodeficiency syndrome	6.94e-05	0.000757	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.89e-05	0.000753	CbGpPWpGaD
Sucralfate—ALB—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	6.83e-05	0.000746	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.75e-05	0.000737	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.75e-05	0.000737	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	6.74e-05	0.000735	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	6.74e-05	0.000735	CbGpPWpGaD
Sucralfate—FGF2—Disease—CCR5—acquired immunodeficiency syndrome	6.59e-05	0.00072	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—IL6—acquired immunodeficiency syndrome	6.58e-05	0.000718	CbGpPWpGaD
Sucralfate—EGF—Disease—CD4—acquired immunodeficiency syndrome	6.54e-05	0.000714	CbGpPWpGaD
Sucralfate—EGF—Immune System—IL2—acquired immunodeficiency syndrome	6.52e-05	0.000712	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—TNF—acquired immunodeficiency syndrome	5.84e-05	0.000638	CbGpPWpGaD
Sucralfate—FGA—Disease—IL6—acquired immunodeficiency syndrome	5.67e-05	0.000619	CbGpPWpGaD
Sucralfate—ALB—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	5.57e-05	0.000608	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—CSF2—acquired immunodeficiency syndrome	5.43e-05	0.000593	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	5.12e-05	0.000559	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	5.05e-05	0.000551	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—IL6—acquired immunodeficiency syndrome	4.71e-05	0.000515	CbGpPWpGaD
Sucralfate—FGF2—Immune System—IFNG—acquired immunodeficiency syndrome	4.64e-05	0.000507	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	4.62e-05	0.000504	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CD4—acquired immunodeficiency syndrome	4.48e-05	0.00049	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.22e-05	0.00046	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—IL6—acquired immunodeficiency syndrome	4.16e-05	0.000455	CbGpPWpGaD
Sucralfate—FGF2—Disease—CD4—acquired immunodeficiency syndrome	4.14e-05	0.000452	CbGpPWpGaD
Sucralfate—FGF2—Immune System—IL2—acquired immunodeficiency syndrome	4.13e-05	0.00045	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.05e-05	0.000442	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.97e-05	0.000433	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.97e-05	0.000433	CbGpPWpGaD
Sucralfate—EGF—Immune System—IL6—acquired immunodeficiency syndrome	3.83e-05	0.000418	CbGpPWpGaD
Sucralfate—EGF—Disease—IL6—acquired immunodeficiency syndrome	3.54e-05	0.000386	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—IL2—acquired immunodeficiency syndrome	2.87e-05	0.000313	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.67e-05	0.000291	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.48e-05	0.00027	CbGpPWpGaD
Sucralfate—FGF2—Immune System—IL6—acquired immunodeficiency syndrome	2.43e-05	0.000265	CbGpPWpGaD
Sucralfate—FGF2—Disease—IL6—acquired immunodeficiency syndrome	2.24e-05	0.000244	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.57e-05	0.000171	CbGpPWpGaD
